G
Gideon Koren
Researcher at Ariel University
Publications - 2007
Citations - 88165
Gideon Koren is an academic researcher from Ariel University. The author has contributed to research in topics: Pregnancy & Population. The author has an hindex of 129, co-authored 1994 publications receiving 81718 citations. Previous affiliations of Gideon Koren include McGill University Health Centre & University of Western Ontario.
Papers
More filters
Journal Article
Chronic HPA Axis Response to Stress in Temporomandibular Disorder
Cynthia Ann Lambert,Anne E. Sanders,Rebecca S. Wilder,Gary D. Slade,Stan Van Uum,Evan Russell,Gideon Koren,William Maixner +7 more
TL;DR: Despite greater perceived stress, TMD cases had lower hair cortisol concentrations than controls and the 2 measures of stress were weakly and negatively correlated.
Journal ArticleDOI
An investigation into variability in the therapeutic response to deferiprone in patients with thalassemia major.
TL;DR: Regression analysis suggested that patients with initial hepatic iron concentration of less than or equal to 7.22 mg/g of dry weight liver tissue are unlikely to further decrease while taking deferiprone, and provided evidence that its effectiveness decreases in proportion to liver iron load.
Journal Article
Lead exposure among mothers and their newborns in Toronto
TL;DR: The data suggest that living in Toronto does not impose increased teratogenic risk from intrauterine exposure to lead; however, residents in high-risk areas should be followed up.
Journal ArticleDOI
Comparison of sublingual vs. intramuscular administration of vitamin B12 for the treatment of patients with vitamin B12 deficiency.
Merav Jacobson Bensky,Irit Ayalon-Dangur,Roi Ayalon-Dangur,Eviatar Naamany,Anat Gafter-Gvili,Anat Gafter-Gvili,Gideon Koren,Shachaf Shiber,Shachaf Shiber +8 more
TL;DR: The largest study that documents therapy with SL preparations of VB12 sufficient and even superior to the IM route concludes that the SL overcomes the challenges of IM injections and should be the first line option for patients with VB 12d.
Journal ArticleDOI
Treating morning sickness in the United States—changes in prescribing are needed
TL;DR: Now that a safe and effective drug is available in the United States, there is no reason for women to be exposed to a drug of unproven maternal and fetal safety.